Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-23-010491

Options or other derivatives

  • President and CEO acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fordyce Marshall President and CEO 2023-02-15 Grant or award · Stock Option (right to buy) +450,000 450,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…